The past thirty years have been a period of intense methodological development in statistics, with ideas such as proportional likelihood, robust estimation, jackknife/bootstrap methods, empirical Bayes techniques, longitudinal estimation, and EM algorithm becoming important. The long term purpose of this application is to shorten the transfer time between promising theoretical/methodological innovations and their biostatistical applications. This usually means linking the new methods to established statistical theory, and making clear their data- analytic advantages. the applicants' research is pursued from both the Stanford statistics department and medical school. Four areas are proposed here as focal points for forthcoming research: the use of complicance data in the analysis of clinical trials; bootstrap methods particularly as applied to bias-correction, metaanalysis, prediction, and the construction of confidence ellipsoids; Monte Carlo Markov chain estimators for the analysis of the type of contingency tables arising form genetic marker data; and practical formulas for simultaneous hypothesis testing, based on Hotelling's geometric arguments. Some of this work will be carried out in collaboration with biomedical researchers working on arthritis, AIDS, cardiovascular disease, genetics research, and other diseases in which compliance measurements are particularly useful.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA059039-22
Application #
2008213
Study Section
Special Emphasis Panel (ZRG7-SSS-1 (23))
Program Officer
Erickson, Burdette (BUD) W
Project Start
1993-01-15
Project End
1998-12-31
Budget Start
1997-03-15
Budget End
1997-12-31
Support Year
22
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Stanford University
Department
Biostatistics & Other Math Sci
Type
Schools of Arts and Sciences
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Rath, Barbara A; Yousef, Kaveh Pouran; Katzenstein, David K et al. (2013) In vitro HIV-1 evolution in response to triple reverse transcriptase inhibitors & in silico phenotypic analysis. PLoS One 8:e61102
Rath, Barbara A; Olshen, Richard A; Halpern, Jerry et al. (2012) Persistence versus reversion of 3TC resistance in HIV-1 determine the rate of emergence of NVP resistance. Viruses 4:1212-34
Bhamre, S; Nuzzo, R L; Whitin, J C et al. (2000) Intracellular reduction of selenite into glutathione peroxidase. Evidence for involvement of NADPH and not glutathione as the reductant. Mol Cell Biochem 211:17-Sep
Lin, A; Lenert, L A; Hlatky, M A et al. (1999) Clustering and the design of preference-assessment surveys in healthcare. Health Serv Res 34:1033-45
Sugar, C A; Sturm, R; Lee, T T et al. (1998) Empirically defined health states for depression from the SF-12. Health Serv Res 33:911-28
Buckheit, J B; Olshen, R A; Blouch, K et al. (1997) Modeling of progressive glomerular injury in humans with lupus nephritis. Am J Physiol 273:F158-69
Lech, W J; Wang, G; Yang, Y L et al. (1996) In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects. J Virol 70:2038-43
Bickel, P J; Cosman, P C; Olshen, R A et al. (1996) Covariability of V3 loop amino acids. AIDS Res Hum Retroviruses 12:1401-11
Efron, B; Halloran, E; Holmes, S (1996) Bootstrap confidence levels for phylogenetic trees. Proc Natl Acad Sci U S A 93:7085-90
Efron, B; Halloran, E; Holmes, S (1996) Bootstrap confidence levels for phylogenetic trees. Proc Natl Acad Sci U S A 93:13429-34

Showing the most recent 10 out of 11 publications